US20070020330A1 - Compositions comprising azelastine and methods of use thereof - Google Patents

Compositions comprising azelastine and methods of use thereof Download PDF

Info

Publication number
US20070020330A1
US20070020330A1 US11/486,454 US48645406A US2007020330A1 US 20070020330 A1 US20070020330 A1 US 20070020330A1 US 48645406 A US48645406 A US 48645406A US 2007020330 A1 US2007020330 A1 US 2007020330A1
Authority
US
United States
Prior art keywords
azelastine
fluticasone
sucralose
lt
loteprednol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/486,454
Inventor
Phuong Dang
Brian Lawrence
Gul Balwani
Alexander D'Addio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharmaceuticals Inc
Original Assignee
MedPointe Healthcare Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US63027404P priority Critical
Priority to US11/284,109 priority patent/US8071073B2/en
Application filed by MedPointe Healthcare Inc filed Critical MedPointe Healthcare Inc
Priority to US11/486,454 priority patent/US20070020330A1/en
Assigned to MEDPOINTE HEALTHCARE INC. reassignment MEDPOINTE HEALTHCARE INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BALWANI, GUL, D'ADDIO, ALEXANDER D., DANG, PHUONG GRACE, LAWRENCE, BRIAN D.
Publication of US20070020330A1 publication Critical patent/US20070020330A1/en
Assigned to MEDA PHARMACEUTICALS INC. reassignment MEDA PHARMACEUTICALS INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MEDPOINTE HEALTHCARE INC.
Priority claimed from US12/569,548 external-priority patent/US8758816B2/en
Application status is Abandoned legal-status Critical

Links